Evidence for a role of IL-17 in alloimmunity: A novel IL-17 antagonist promotes heart graft survival

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 93-

  Antonysamy, M A ^a,b   Fanslow, W C ^a,b   Fu, F ^a,b   Li, W ^a,b   Qian, S ^a,b   Troutt, A B ^a,b   Thomson, A W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 17 ANTAGONIST; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; DENDRITIC CELL; DRUG EFFECT; DRUG SCREENING; GRAFT SURVIVAL; HEART GRAFT; HISTOINCOMPATIBILITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DENDRITIC CELLS; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED STRAINS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0344457228     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01453-5     Document Type: Conference Paper

References (4)

1. Yao Z., Fanslow W.C., Seldin M.F., et al. Immunity. 3:1995;811.
2. Fossiez F., Djossou O., Chomarat P., et al. J Exp Med. 183:1996;2593.
3. Antonysamy M.A., Lotze M.T., Tahara H., et al. Thomson A.W. The Cytokine Handbook. 1998;465 Academic Press, San Diego, Calif.
4. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., et al. J Immunol. 160:1998;3513.